• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用登革病毒E蛋白结构域I/II而非结构域III进行DNA免疫,会增强寨卡病毒、西尼罗河病毒和黄热病病毒的感染。

DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.

作者信息

Slon Campos Jose L, Poggianella Monica, Marchese Sara, Mossenta Monica, Rana Jyoti, Arnoldi Francesca, Bestagno Marco, Burrone Oscar R

机构信息

Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

出版信息

PLoS One. 2017 Jul 25;12(7):e0181734. doi: 10.1371/journal.pone.0181734. eCollection 2017.

DOI:10.1371/journal.pone.0181734
PMID:28742857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5526558/
Abstract

Dengue virus (DENV), the causative agent of dengue disease, is among the most important mosquito-borne pathogens worldwide. DENV is composed of four closely related serotypes and belongs to the Flaviviridae family alongside other important arthropod-borne viral pathogens such as Zika virus (ZIKV), West Nile virus (WNV) and Yellow Fever virus (YFV). After infection, the antibody response is mostly directed to the viral E glycoprotein which is composed of three structural domains named DI, DII and DIII that share variable degrees of homology among different viruses. Recent evidence supports a close serological interaction between ZIKV and DENV. The possibility of worse clinical outcomes as a consequence of antibody-dependent enhancement of infection (ADE) due to cross-reactive antibodies with poor neutralisation activity is a matter of concern. We tested polyclonal sera from groups of female Balb/C mice vaccinated with DNA constructs expressing DI/DII, DIII or the whole sE from different DENV serotypes and compared their activity in terms of cross-reactivity, neutralisation of virus infection and ADE. Our results indicate that the polyclonal antibody responses against the whole sE protein are highly cross-reactive with strong ADE and poor neutralisation activities due to DI/DII immunodominance. Conversely, anti-DIII polyclonal antibodies are type-specific, with no ADE towards ZIKV, WNV and YFV, and strong neutralisation activity restricted only to DENV.

摘要

登革病毒(DENV)是登革热疾病的病原体,是全球最重要的蚊媒病原体之一。DENV由四种密切相关的血清型组成,与其他重要的节肢动物传播病毒病原体,如寨卡病毒(ZIKV)、西尼罗河病毒(WNV)和黄热病病毒(YFV)同属黄病毒科。感染后,抗体反应主要针对病毒E糖蛋白,该蛋白由三个结构域DI、DII和DIII组成,不同病毒之间这些结构域具有不同程度的同源性。最近的证据支持ZIKV和DENV之间存在密切的血清学相互作用。由于具有不良中和活性的交叉反应抗体导致感染的抗体依赖性增强(ADE),从而产生更差临床结果的可能性令人担忧。我们检测了用表达不同DENV血清型的DI/DII、DIII或全长sE的DNA构建体免疫的雌性Balb/C小鼠组的多克隆血清,并比较了它们在交叉反应性、病毒感染中和及ADE方面的活性。我们的结果表明,针对全长sE蛋白的多克隆抗体反应具有高度交叉反应性,由于DI/DII免疫显性,具有强烈的ADE和不良的中和活性。相反,抗DIII多克隆抗体具有型特异性,对ZIKV、WNV和YFV无ADE,且强烈的中和活性仅局限于DENV。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/c1ee3f797d00/pone.0181734.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/50924b530154/pone.0181734.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/e59679727584/pone.0181734.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/f1edc6c6e860/pone.0181734.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/9ef656c95617/pone.0181734.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/74f9e1631d56/pone.0181734.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/c1ee3f797d00/pone.0181734.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/50924b530154/pone.0181734.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/e59679727584/pone.0181734.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/f1edc6c6e860/pone.0181734.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/9ef656c95617/pone.0181734.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/74f9e1631d56/pone.0181734.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/5526558/c1ee3f797d00/pone.0181734.g006.jpg

相似文献

1
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.用登革病毒E蛋白结构域I/II而非结构域III进行DNA免疫,会增强寨卡病毒、西尼罗河病毒和黄热病病毒的感染。
PLoS One. 2017 Jul 25;12(7):e0181734. doi: 10.1371/journal.pone.0181734. eCollection 2017.
2
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
3
Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.登革热和 Zika 病毒结构域 III-鞭毛蛋白融合和糖基掩蔽 E 抗原用于初次-加强免疫。
Theranostics. 2019 Jul 9;9(16):4811-4826. doi: 10.7150/thno.35919. eCollection 2019.
4
Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.鉴定抗前膜抗体作为血清复合物特异性标志物以区分寨卡病毒、登革热病毒和西尼罗河病毒感染
J Virol. 2021 Sep 9;95(19):e0061921. doi: 10.1128/JVI.00619-21.
5
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.减毒黄病毒疫苗诱导的 T 细胞反应具有特异性,与其他黄病毒种属表现出有限的交叉反应性。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00089-20.
6
Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection.西尼罗河病毒血清阳性且无临床感染史个体的抗体增强寨卡病毒感染。
BMC Immunol. 2021 Jan 9;22(1):5. doi: 10.1186/s12865-020-00389-2.
7
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.抗体依赖性增强作用对登革热/寨卡病毒致病性的调节作用及寨卡病毒感染中预防增强作用的策略。
Front Immunol. 2018 Apr 23;9:597. doi: 10.3389/fimmu.2018.00597. eCollection 2018.
8
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.登革热和 Zika 病毒感染可被减毒活疫苗增强,但在小鼠模型中,重组 DSV4 候选疫苗不会增强登革热感染。
EBioMedicine. 2020 Oct;60:102991. doi: 10.1016/j.ebiom.2020.102991. Epub 2020 Sep 16.
9
Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses.既往登革热或寨卡病毒感染可导致其他黄病毒的感染增强或中和。
Mem Inst Oswaldo Cruz. 2019;114:e190098. doi: 10.1590/0074-02760190098. Epub 2019 Aug 12.
10
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.一种经包膜修饰的四价登革病毒样颗粒疫苗对黄病毒疫苗设计具有启示意义。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01181-17. Print 2017 Dec 1.

引用本文的文献

1
Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue.新型登革热减毒活疫苗候选株的研发:无抗体依赖增强(ADE)作用
Vaccines (Basel). 2025 May 16;13(5):532. doi: 10.3390/vaccines13050532.
2
EDIII-Fc induces protective immune responses against the Zika virus in mice and rhesus macaque.EDIII-Fc 诱导小鼠和恒河猴对寨卡病毒产生保护性免疫应答。
PLoS Negl Trop Dis. 2023 Nov 20;17(11):e0011770. doi: 10.1371/journal.pntd.0011770. eCollection 2023 Nov.
3
Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain.

本文引用的文献

1
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope.共价连接的登革病毒包膜糖蛋白二聚体减少免疫显性融合环表位的暴露。
Nat Commun. 2017 May 23;8:15411. doi: 10.1038/ncomms15411.
2
Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.温度依赖型折叠使登革热和 Zika 病毒的分泌型和病毒相关 E 蛋白在哺乳动物细胞中能够稳定二聚化。
Sci Rep. 2017 Apr 19;7(1):966. doi: 10.1038/s41598-017-01097-5.
3
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.
通过突变独特抗原域开发低交叉反应性黄病毒亚病毒颗粒。
Appl Microbiol Biotechnol. 2023 Dec;107(24):7515-7529. doi: 10.1007/s00253-023-12817-5. Epub 2023 Oct 13.
4
Nanobodies Selectively Binding to the Idiotype of a Dengue Virus Neutralizing Antibody Do Not Necessarily Mimic the Viral Epitope.纳米抗体特异性结合登革病毒中和抗体的独特型并不一定模拟病毒表位。
Biomolecules. 2023 Mar 17;13(3):551. doi: 10.3390/biom13030551.
5
Zika Virus Envelope Protein Domain III Produced in Has the Potential for Diagnostic Applications.在[具体生产环境]中产生的寨卡病毒包膜蛋白结构域III具有诊断应用潜力。 (注:原文中“Produced in”后面缺少具体内容)
Diagnostics (Basel). 2022 May 11;12(5):1198. doi: 10.3390/diagnostics12051198.
6
Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract.基于麻疹的寨卡疫苗可诱导长期免疫,且需要NS1抗体来保护女性生殖道。
NPJ Vaccines. 2022 Apr 19;7(1):43. doi: 10.1038/s41541-022-00464-2.
7
Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection.西尼罗河病毒血清阳性且无临床感染史个体的抗体增强寨卡病毒感染。
BMC Immunol. 2021 Jan 9;22(1):5. doi: 10.1186/s12865-020-00389-2.
8
Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil.在一个风险地区,与黄病毒和基孔肯雅热感染相关的血清流行率、空间分布和因素:巴西的一项基于人群的血清流行率研究。
BMC Infect Dis. 2020 Nov 24;20(1):881. doi: 10.1186/s12879-020-05611-5.
9
Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise.蜱传脑炎病毒:寻求针对一种日益流行病毒的更好疫苗
Vaccines (Basel). 2020 Aug 12;8(3):451. doi: 10.3390/vaccines8030451.
10
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines.寨卡病毒包膜结构域III在DNA、蛋白质和ChAdOx1腺病毒载体疫苗中的免疫原性和效力
Vaccines (Basel). 2020 Jun 16;8(2):307. doi: 10.3390/vaccines8020307.
既往抗黄病毒免疫增强寨卡病毒致病性
Science. 2017 Apr 14;356(6334):175-180. doi: 10.1126/science.aal4365. Epub 2017 Mar 30.
4
Modified mRNA Vaccines Protect against Zika Virus Infection.改良型信使核糖核酸疫苗可预防寨卡病毒感染。
Cell. 2017 Mar 9;168(6):1114-1125.e10. doi: 10.1016/j.cell.2017.02.017. Epub 2017 Feb 17.
5
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.单次低剂量核苷修饰的mRNA疫苗对寨卡病毒的防护作用
Nature. 2017 Mar 9;543(7644):248-251. doi: 10.1038/nature21428. Epub 2017 Feb 2.
6
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity.对FcγRIIIA结合增强的登革热IgG抗体决定疾病严重程度。
Science. 2017 Jan 27;355(6323):395-398. doi: 10.1126/science.aai8128.
7
Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation.寨卡病毒疫情的预防性疫苗:初步评估
EBioMedicine. 2016 Nov;13:315-320. doi: 10.1016/j.ebiom.2016.09.028. Epub 2016 Oct 3.
8
Rapid development of a DNA vaccine for Zika virus.寨卡病毒DNA疫苗的快速研发。
Science. 2016 Oct 14;354(6309):237-240. doi: 10.1126/science.aai9137. Epub 2016 Sep 22.
9
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity.交叉反应性抗体增强减毒活病毒感染以提高免疫原性。
Nat Microbiol. 2016 Sep 19;1(12):16164. doi: 10.1038/nmicrobiol.2016.164.
10
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.多种疫苗平台对恒河猴寨卡病毒攻击的保护效力
Science. 2016 Sep 9;353(6304):1129-32. doi: 10.1126/science.aah6157. Epub 2016 Aug 4.